Cargando…
Genetic markers of artemisinin resistance in Plasmodium spp. parasites
The vast majority of malaria patients worldwide are currently treated with combination therapy comprising one of the artemisinin family of drugs, characterised by rapid action and short plasma half-life, co-formulated with a longer-lasting drug from the amino aryl-alcohol or quinoline families. Ther...
Autor principal: | Sutherland, Colin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288991/ https://www.ncbi.nlm.nih.gov/pubmed/33525848 http://dx.doi.org/10.1042/ETLS20170100 |
Ejemplares similares
-
Artemisinin susceptibility in the malaria parasite Plasmodium falciparum: propellers, adaptor proteins and the need for cellular healing
por: Sutherland, Colin J, et al.
Publicado: (2020) -
The primate malaria parasites Plasmodium malariae, Plasmodium brasilianum and Plasmodium ovale spp.: genomic insights into distribution, dispersal and host transitions
por: Fuehrer, Hans-Peter, et al.
Publicado: (2022) -
Artemisinin-based antimalarial research: application of biotechnology to the production of artemisinin, its mode of action, and the mechanism of resistance of Plasmodium parasites
por: Muangphrom, Paskorn, et al.
Publicado: (2016) -
Plasmodium falciparum: multifaceted resistance to artemisinins
por: Paloque, Lucie, et al.
Publicado: (2016) -
Genetically Determined Response to Artemisinin Treatment in Western Kenyan Plasmodium falciparum Parasites
por: Chebon, Lorna J., et al.
Publicado: (2016)